Atlas Trials

Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer

Clinical trial NCT00070122 · TERMINATED

Trial details

NCT number
NCT00070122
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon CancerRecurrent Rectal CancerStage III Colon CancerStage III Rectal CancerStage IV Colon CancerStage IV Rectal Cancer
Start date
2004-04-01
Primary completion
2007-01-01
Enrollment
2200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.